Influence of Fructose-1,6-Diphosphate on Endotoxin-Induced Lung Injuries in Sheep

Journal of Surgical Research

Volumn 138, Issue 1, 2007, Pages 45-50

  Markov, Angel K ^a   Warren, E Taliferio ^a   Cohly, Hari H P ^b   Sauls, David J ^a   Skelton, Thomas N ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b Jackson State University   (United States)

Author keywords

endotoxin; fructose 1,6 diphosphate; leukocytes; lung lymph protein clearance; pulmonary arterial pressure; sheep; wet dry weight ratio

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE; LYMPH PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BOLUS INJECTION; CANNULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; LEUKOCYTE COUNT; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG INJURY; LUNG LYMPH; LUNG RESISTANCE; LUNG WEIGHT; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHEEP; THORACOTOMY;

ANIMALS; CARDIOVASCULAR AGENTS; ENDOTOXEMIA; ENDOTOXINS; EXTRAVASCULAR LUNG WATER; FRUCTOSEDIPHOSPHATES; HYPERTENSION, PULMONARY; LEUKOCYTE COUNT; LYMPH; PULMONARY WEDGE PRESSURE; RESPIRATORY DISTRESS SYNDROME, ADULT; SHEEP; VASCULAR RESISTANCE;

EID: 33846892038     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.06.038     Document Type: Article

References (44)

1. Snell J., and Ramsey L.H. Pulmonary edema as a result of endotoxemia. Am J Physiol 217 (1969) 170
2. Reeves T., Daoud F., and Estridge M. Pulmonary hypertension produced by minute amounts of endotoxin in calves. J Appl Physiol 33 (1972) 739
3. Brigham K.L., Bowers R.E., and Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 45 (1979) 292
4. Traber D.L., Adair T.H., and Adams Jr. T. Hemodynamic consequences of endotoxemia in sheep. Circ Shock 8 (1981) 551
5. Markov A.K., Turner M.D., Oglethorpe N., and Hellems H.K. Fructose-1, 6-diphosphate: An agent for treatment of experimental endotoxin shock. Surgery 90 (1981) 482
6. Markov A.K., Oglethorpe N., Grillis M., Neely W.A., and Hellems H.K. Therapeutic action of fructose 1-6 diphosphate in traumatic shock. World J Surg 7 (1983) 430
7. Markov A.K., Terry J.W., White T.Z., Didlake R.H., and Hellems H.K. Increasing survival of dogs subjected to hemorrhagic shock with fructose 1-6 diphosphate. Surgery 102 (1987) 515
8. Figueroa A.H., Stone R.H., Cohly H.H.P., Lehan P.H., and Markov A.K. Effect of fructose-1,6-diphosphate versus diphenhydramine on mortality in compound 48/80-induced shock. Toxicol Lett 122 (2001) 141
9. Nunes F.B., Simoes Pires M.G., Farias Alves Filho J.C., Wachter P.H., and Rodrigues De Oliveira J. Physiopathological studies in septic rats and the use of fructose 1,6-bisphosphate as cellular protection. Crit Care Med 30 (2002) 2069
10. Markov A.K. Hemodynamic and metabolic effects of fructose-1,6-diphosphate (FDP) in ischemia and shock-experimental and clinical observations. Ann Emerg Med 15 (1986) 1470
11. Markov A.K., Causey A.L., Didlake R.H., and Lemos L.B. Prevention of αnaphthylthiourea-induced pulmonary edema with fructose-1, 6-diphosphate. Exper Lung Res 28 (2002) 285
12. Taylor A.E., Martin D., and Parker J.C. The effects of oxygen radicals on pulmonary edema formation. Surgery 94 (1983) 433
13. Repine J.E., Bowman M.C., and Tate R.M. Neutrophils and lung edema. Chest 81 (1982) 475
14. Craddock P.R., Fehr J., Brigham K.L., Kronenberg R.S., and Jacob H.S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296 (1977) 769
15. Flick M.R., Perel A., and Staub N.C. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ Res 48 (1981) 344
16. Schinetti M.L., and Lazzarino G. Inhibition of phorbol ester-stimulated chemiluminescence and superoxide production in human neutrophils by fructose 1,6-diphosphate. Biochem Pharmacol 35 (1986) 1762
17. Markov A.K., Finch C.D., and Hellems H.K. Prevention of superoxide generation and inhibition of oxygen burst in human and canine neutrophils with fructose 1-6 diphosphate (FDP). In: Tsuchiya N.I., Asano M., Mishima Y., and Oda M. (Eds). Microcirculation: An update Vol 1 (1987), Elsevier, Amsterdam 691
18. Markov A.K., Lovell F.A., Grogan L.B., and Hellems H.K. Inhibition of leukocyte respiratory burst in luminol- and lucigenin-enhanced chemiluminescence (CL) by fructose 1-6 diphosphate (FDP). In: Tsuchiya M., Asano M., Mishima Y., and Oda M. (Eds). Microcirculation: An update (1987), Elsevier, Amsterdam 709
19. Thomassen M.J., Meeker D.P., Antal J.M., Connors M.J., and Wiedemann H.P. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7 (1992) 252
20. Sone Y., Serikov V.B., and Staub N.C. Intravascular macrophage depletion attenuates endotoxin lung injury in anesthetized sheep. J Appl Physiol 87 (1999) 1354
21. Staub N.C., Longwortb K.E., Serikov V., Jerome E.H., and Elsasser T. Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep. J Appl Physiol 90 (2001) 1788
22. Markov A.K., Rayburn T.S., Talton D.S., et al. Fructose-I, 6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression. Transplantation 74 (2002) 1651
23. Cohly H., Jenkins J., Skelton T., Meydrech E., and Markov A.K. Fructose-I, 6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, β-actin mRNAs, and transcription factors expression. Immunol Invest 33 (2004) 407
24. Tanuki T., Nakai T., and Yamaue H. Fructose-I, 6-bisphosphate inhibits excess activation of Kupftèr cell function induced by endotoxin. Dig Dis Sci 47 (2002) 2179
25. Sigurdsson G.H., and Christenson J.T. Influence of terbutaline on endotoxin-induced lung injury. Circ Shock 25 (1988) 153
26. Michel R.P., Hakim T.S., Smith T.J., and Poulsen R.S. Quantitative morphology of permeability lung edema in dogs induced by alpha-naphthylthiourea. Lab Invest 49 (1983) 412
27. Moosavi H., Utell M.J., Hyde R.W., et al. Lung ultrastructure in noncardiogenic pulmonary edema induced by air embolization in dogs. Lab Invest 45 (1981) 456
28. Robin E., Carey L., Grenvick A., Glauser F., and Gaudio K. Capillary leak syndrome with pulmonary edema. Arch Intern Med 130 (1972) 66
29. Robin E., Cross C., and Zelis R. Pulmonary edema. N Engl J Med 288 (1973) 239
30. Finley R.J., Holliday R.L., Lefroe M., and Dug J.H. Pulmonary edema in patients with sepsis. Surg Gynecl Obstet 140 (1975) 851
31. Brigham K., Woolverton W., Blake L., and Staub N. Increased sheep lung vascular permeability caused by Pseudomonas bacteremia. J Clin Invest 54 (1974) 792
32. Drinker C.K., and Hardenbergh E. Acute effects upon the lungs of dogs of large intravenous doses of alpha-naphthylthiourea (ANTU). Am J Physiol 156 (1949) 35
33. Cunningham A.L., and Harley J.V. Alpha-naphthylthiourea-induced pulmonary edema in the rat: A topographical and electron-microscope study. J Pathol 106 (1972) 25
34. Rutili G., Kvietys P., Martin D., Parker J.C., and Taylor A.E. Increased pulmonary microvascular permeability induced by alpha-naphthylthiourea. J Appl Physiol 52 (1982) 1316
35. Heflin Jr. A.C., and Brigham K.L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 68 (1981) 1253
36. Milligan S.A., Hoeffel J.M., Goldstein I.M., and Flick M. Effect of catalase on endotoxin-induced acute lung injury in unanesthetized sheep. Am Rev Respir Dis 137 (1988) 420
37. Flick M.R., Hoeffel J.M., and Staub N.C. Superoxide dismutase with heparin prevents increased lung vascular permeability after microemboli [abstract]. Fed Proc 40 (1981) 405
38. Parker J.C., Martin D.J., Rutili U., McCord J., and Taylor A.E. Prevention of free radical mediated vascular permeability increases in lung using superoxide dismutase. Chest 83 (1983) 52S
39. Akimitsu T., White J.A., Carden D.L., Gute D.C., and Korthuis R.I. Fructose-l, 6-diphosphate or adenosine attenuates leukocyte adherence in postischemic skeletal muscle. Am J Physiol 269 (1995) H1743
40. Didlake R.H., Kirchner K., Lewin J., Bower J.D., and Markov A.K. Attenuation of ischemic renal injury with fructose-1,6-diphosphate. J Surg Res 47 (1989) 220
41. Sun J., Farias L.A., and Markov A.K. Fructose-1,6-diphosphate prevents intestinal ischemic reperfission injury and death in rats. Gastroenterology 98 (1990) 117
42. Farias L.A., Smith E.E., and Markov A.K. Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke 21 (1990) 606
43. Kirtley M.E., and McKay M. Fructose-1,6-diphosphate, a regulator of metabolism. Mol Cell Biochem 18 (1977) 141
44. Martin D.J., Parker J.C., and Taylor A.E. Effect of fructose-1,6-diphosphate (FDP) on pulmonary vascular damage associated with a-naphthylthiourea (ANTU). Fed Proc 42 (1983) 1108